HELEN HESLOP to Oncolytic Virotherapy
This is a "connection" page, showing publications HELEN HESLOP has written about Oncolytic Virotherapy.
Connection Strength
0.174
-
Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Sci Adv. 2023 03 29; 9(13):eade6790.
Score: 0.174
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.